0001209191-23-006305.txt : 20230202 0001209191-23-006305.hdr.sgml : 20230202 20230202174236 ACCESSION NUMBER: 0001209191-23-006305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vig Pamela CENTRAL INDEX KEY: 0001780069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 23582527 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-31 0 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001780069 Vig Pamela C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 0 1 0 0 Head of Research & Development Common Stock 2023-01-31 4 A 0 9625 0.00 A 31527 D Common Stock 75000 I By The Vig-Ancock Family Trust Stock Option (right to buy) 23.48 2023-01-31 4 A 0 38500 0.00 A 2033-01-30 Common Stock 38500 38500 D Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan. 1/4th of the shares vest one year after January 31, 2023 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. /s/ Jody Howe, Attorney-in-Fact 2023-02-02